Home > News > A Rexahn, UMD Partnership
February 9th, 2006
Abstract:
Rexahn Pharmaceuticals Inc., a Rockville biotech company, is partnering with University of Maryland School of Pharmacy's Center for Nanomedicine and Cellular Delivery to develop drugs targeting cancer and central nervous system disorders. (last article on the page)
Source:
washingtonpost.com
Related Links |
Center for Nanomedicine and Cellular Delivery
Related News Press |
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||